Tag: autonomous drug design

Clinical Trials, News, Research and Development

AI Drug Developer Exscientia Closes $525M in Financing

April 28, 2021

Via: Genetic Engineering and Biotechnology News

Artificial intelligence (AI)-based drug developer Exscientia has closed on $525 million in financing, with the proceeds intended for advancing its pipeline through clinical trials, as well as expanding its technology platform toward autonomous drug design. Based in Oxford, U.K., Exscientia […]